Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lisak, RP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Khan, OA; Zvartau-Hind, M; Caon, C; Din, MU; Cochran, M; Lisak, D; Tselis, AC; Kamholz, JA; Garbern, JY; Lisak, RP
      Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy

      MULTIPLE SCLEROSIS
    2. Khan, OA; Tselis, AC; Kamholz, JA; Garbern, JY; Lewis, RA; Lisak, RP
      Appropriate design and outcome measures in multiple sclerosis clinical trials - Response

      EUROPEAN JOURNAL OF NEUROLOGY
    3. Khan, OA; Tselis, AC; Kamholz, JA; Garbern, JY; Lewis, RA; Lisak, RP
      A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFN beta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

      EUROPEAN JOURNAL OF NEUROLOGY
    4. Balabanov, R; Lisak, D; Beaumont, T; Lisak, RP; Dore-Duffy, P
      Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: Effect of glatiramer acetate (Copolymer 1)

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    5. Lisak, RP; Bealmear, B; Benjamins, JA; Skoff, AM
      Interferon-gamma, tumor necrosis factor-alpha, and transforming growth factor-beta inhibit cyclic AMP-induced Schwann cell differentiation

      GLIA
    6. Skundric, DS; Lisak, RP; Rouhi, M; Kieseier, BC; Jung, S; Hartung, HP
      Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions

      JOURNAL OF NEUROIMMUNOLOGY
    7. Latov, N; Chaudhry, V; Koski, CL; Lisak, RP; Apatoff, BR; Hahn, AF; Howard, JF
      Use of intravenous gamma globulins in neuroimmunologic diseases

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    8. Johnson, KP; Brooks, BR; Ford, CC; Goodman, A; Guarnaccia, J; Lisak, RP; Myers, LW; Panitch, HS; Pruitt, A; Rose, JW; Kachuck, N; Wolinsky, JS
      Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

      MULTIPLE SCLEROSIS
    9. Lisak, RP
      Type I interferons and chronic inflammatory demyelinating polyneuropathy: Treatment or cause?

      MUSCLE & NERVE
    10. Zvartau-Hind, M; Din, MU; Gilani, A; Lisak, RP; Khan, OA
      Topiramate relieves refractory trigeminal neuralgia in MS patients

      NEUROLOGY
    11. Goldberg, SH; Albright, AV; Lisak, RP; Gonzalez-Scarano, F
      Polymerase chain reaction analysis of human herpesvirus-6 sequences in thesera and cerebrospinal fluid of patients with multiple sclerosis

      JOURNAL OF NEUROVIROLOGY
    12. Tselis, AC; Lisak, RP
      Multiple sclerosis - Therapeutic update

      ARCHIVES OF NEUROLOGY
    13. Ford, CC; Brooks, BR; Johnson, KP; Lisak, RP; Myers, LW; Panitch, HS; Rose, JW; Schiffer, RB; Vollmer, T; Weiner, LP; Wolinsky, JS
      Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS

      MULTIPLE SCLEROSIS
    14. SKOFF AM; LISAK RP; BEALMEAR B; BENJAMINS JA
      TNF-ALPHA AND TGF-BETA ACT SYNERGISTICALLY TO KILL SCHWANN-CELLS

      Journal of neuroscience research
    15. LISAK RP; BEALMEAR BM
      INFLAMMATORY CYTOKINES INHIBIT CAMP-INDUCTION OF GLYCOLIPIDS BY SCHWANN-CELL

      Neurology
    16. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS
      EXTENDED USE OF GLATIRAMER ACETATE (COPAXONE) IS WELL TOLERATED AND MAINTAINS ITS CLINICAL EFFECT ON MULTIPLE-SCLEROSIS RELAPSE RATE AND DEGREE OF DISABILITY

      Neurology
    17. Lisak, RP
      Intravenous immunoglobulins in multiple sclerosis

      NEUROLOGY
    18. Lisak, RP; Bealmear, B; Benjamins, J; Skoff, A
      Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro

      NEUROLOGY
    19. LISAK RP
      UNTITLED

      Journal of the neurological sciences
    20. SKUNDRIC DS; BEALMEAR B; ROUHI M; LISAK RP
      IMMUNOSTIMULATORY EFFECT OF TGF-BETA IS DOWN-REGULATED BY GROWTH-FACTOR TREATMENT OF SCHWANN-CELLS (SC)

      Journal of neurochemistry
    21. SKOFF AM; BEALMEAR B; BENJAMINS JA; LISAK RP
      TNF-ALPHA UP-REGULATES NF-KAPPA-B IN CULTURED RAT SCHWANN-CELLS

      Journal of neurochemistry
    22. SKUNDRIC DS; BEALMEAR B; LISAK RP
      INDUCED UP-REGULATION OF IL-I, IL-1RA AND IL-1R TYPE-I GENE-EXPRESSION BY SCHWANN-CELLS

      Journal of neuroimmunology
    23. TSELIS A; DUMAN R; STORCH GA; LISAK RP
      EPSTEIN-BARR-VIRUS ENCEPHALOMYELITIS DIAGNOSED BY POLYMERASE CHAIN-REACTION - DETECTION OF THE GENOME IN THE CSF

      Neurology
    24. SKUNDRIC DS; BEALMEAR B; LISAK RP
      IL-1-BETA, IL-6 AND TNF-ALPHA UP-REGULATE GENE-EXPRESSION OF EACH OTHER IN CULTURED SCHWANN-CELLS (SC)

      Journal of neurochemistry
    25. LISAK RP; SKUNDRIC D; BEALMEAR B; RAGHEB S
      THE ROLE OF CYTOKINES IN SCHWANN-CELL DAMAGE, PROTECTION, AND REPAIR

      The Journal of infectious diseases
    26. LISAK RP
      LIVER-FUNCTION IN GBS

      Neurology
    27. LISAK RP; BEALMEAR B; BENJAMINS J; YU C; SKOFF R
      TRANSFORMING GROWTH-FACTOR-BETA HAS DIFFERENT EFFECTS ON PROLIFERATION OF NEONATAL CENTRAL AND PERIPHERAL MACROGLIA IN-VITRO

      Neurology
    28. LISAK RP
      ARTHRITIS-ASSOCIATED WITH CIRCULATING IMMUNE-COMPLEXES FOLLOWING ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN A PATIENT WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

      Journal of the neurological sciences
    29. SKUNDRIC DS; BEALMEAR B; LISAK RP
      INDUCIBLE COEXPRESSION OF IL-1, IL-6 AND TNF-ALPHA GENES IN SCHWANN-CELLS (SC)

      Journal of neurochemistry
    30. TSELIS AC; LISAK RP
      ACUTE DISSEMINATED ENCEPHALOMYELITIS AND ISOLATED CENTRAL-NERVOUS-SYSTEM DEMYELINATIVE SYNDROMES

      Current opinion in neurology
    31. DOREDUFFY P; NEWMAN W; BALABANOV R; LISAK RP; MAINOLFI E; ROTHLEIN R; PETERSON M
      CIRCULATING, SOLUBLE ADHESION PROTEINS IN CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH MULTIPLE-SCLEROSIS - CORRELATION WITH CLINICAL ACTIVITY

      Annals of neurology
    32. MOORE PM; LISAK RP
      SYSTEMIC LUPUS-ERYTHEMATOSUS - IMMUNOPATHOGENESIS OF NEUROLOGIC DYSFUNCTION

      Perspectives in mathematical logic
    33. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS; BIRD SJ; CONSTANTINESCU C; KOLSON DL; GONZALEZSCARANO F; BRENNAN D; PFOHL D; MANDLER RN; ROSENBERG GA; JEFFREY C; BARGER GR; GANDHI B; MOORE PM; ROGERS LR; LISAK D; SMITH L; ELLISON GW; BAUMHEFNER RW; CRAIG SL; JALBUT SS; KATZ E; CONWAY KL; BURNS JB; SHIBA C; GIANG DW; PETRIE MD; GUARNACCIA JB; ANDERSON S; MCKEON A; MCCARTHY M; THOMAS AB; VRIESENDORP FJ; AUSTIN SG; LINDSEY JW; DIMACHKIE M; CERRETA E; KACHUCK N; MCCARTHY KA; FLEMING J; PARNELL JH; TAMULEVICH J; WEASLER C; KADOSH S; HALT H; STARK Y; PINCHASI I; SPILLER N; VANDENNOORT S; MILLER A; MELLITS D; HOPKINS J; REINGOLD S; GOMOLIN IH
      COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Neurology
    34. LISAK RP; BEALMEAR B
      TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) IS CO-MITOGENIC FOR SCHWANN-CELLS (SC) WITH INTERLEUKIN-1-ALPHA (IL-1-ALPHA)

      Neurology
    35. LISAK RP; BEALMEAR B; RAGHEB S
      INTERLEUKIN-1-ALPHA, BUT NOT INTERLEUKIN-1-BETA, IS A COMITOGEN FOR NEONATAL RAT SCHWANN-CELLS IN-VITRO AND ACTS VIA INTERLEUKIN-1 RECEPTORS

      Journal of neuroimmunology
    36. LISAK RP; BEALMEAR B
      ANTIBODIES TO INTERLEUKIN-6 INHIBIT SCHWANN-CELL PROLIFERATION INDUCED BY UNFRACTIONATED CYTOKINES

      Journal of neuroimmunology
    37. LISAK RP; BEALMEAR B
      INDUCTION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) ON SCHWANN-CELLS (SC) IN-VITRO

      Neurology
    38. RAGHEB S; LISAK RP
      ANTIGENIC DETERMINANTS ON THE EPSILON-SUBUNIT AND GAMMA-SUBUNIT OF THE ACETYLCHOLINE-RECEPTOR INDUCE T-CELL PROLIFERATION IN MYASTHENIA-GRAVIS (MG)

      Neurology
    39. RAGHEB S; LISAK RP
      MULTIPLE-SCLEROSIS - GENETIC BACKGROUND VERSUS ENVIRONMENT

      Annals of neurology
    40. LISAK RP; BEALMEAR B; RAGHEB S
      INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST (IL-1RA) INHIBITS SCHWANN-CELL PROLIFERATION INDUCED BY UNFRACTIONATED CYTOKINES

      Neurology
    41. NADKARNI N; LISAK RP
      GUILLAIN-BARRE-SYNDROME (GBS) WITH BILATERAL OPTIC NEURITIS AND CENTRAL WHITE MATTER DISEASE

      Neurology
    42. RAGHEB S; LISAK RP
      T-CELL RECEPTOR (TCR) V-BETA ELEMENTS IN MYASTHENIA-GRAVIS (MG)

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 18:22:41